JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Way, E. L.
Right arrow Articles by Herbert, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Way, E. L.
Right arrow Articles by Herbert, W. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 104, Issue 2, 115-121, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF SODIUM PENTOBARBITAL ON THE TOXICITY OF CERTAIN ANTIHISTAMINES

E. Leong Way 1 and Woodrow C. Herbert 1

1 Division of Pharmacology, School of Medicine, and the College of Pharmacy, University of California, San Francisco, California

Sodium pentobarbital increases the intraperitoneal LD50 of tripelennamine (Pyribenzamine), diphenhydramine (Benadryl), chlorprophenpyridamine (Chlortrimeton), and phenindamine (Thephorin) in mice. Sodium pentobarbital acts similarly for tripelennamine and diphenhydramine in rats but not for chlorprophenpyridamine. In rats overdosed orally with tripelennamine or diphenhydramine, the death rate is not significantly affected by sodium pentobarbital, although convulsions are aborted in part and survival time may be increased. It is suggested that the degradation products of the antihistamine, which are present in greater amounts after oral administration, may enhance the actions of sodium pentobarbital and contribute to the over-all toxicity.

It is recommended that should the attempt be made in the clinic to antagonize antihistaminic overdosage with a barbiturate, immediate treatment and removal of any unabsorbed material are prime requisites in addition to the usual supportive therapy. The pharmacologic basis for such measures has been discussed.

Submitted on August 13, 1951







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.